Lyfebulb Announces Finalists for the 2022 Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease

Jul 11, 2023

NEW YORKDec. 9, 2022 /PRNewswire/ — Lyfebulb, a patient-empowerment platform that bridges patients with industry to support user-driven innovation, education and connectivity, is pleased to announce the finalists for the 2022 “Addressing Unmet Needs in IBD” Innovation Challenge in collaboration with Bristol Myers Squibb.

Read the full release here: